Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

158.50
Delayed Data
As of Jul 25
 +0.30 / +0.19%
Today’s Change
89.76
Today|||52-Week Range
276.19
+6.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues2.4M1.6M1.7M2.8M
 
 
 
 
 
Depreciation And Amortization201.3K105.7K442.8K1.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.2M41.0M114.5M230.2M
 
 
 
 
 
Research And Development16.2M27.9M80.3M128.2M
 
 
 
 
 
Total Operating Expenses21.4M41.1M114.9M231.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.9M-39.5M-113.2M-229.2M
 
 
 
 
 
Extraordinary Charge-24.8M-28.4M-170.8M0.00
 
 
 
 
Other Expenses87.8K100.4K776.1K2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.6M-67.8M-283.2M-226.4M
 
 
 
 
 
Preferred Dividend-2.6M0.000.000.00
 
 
Net Income-43.6M-67.8M-283.2M-226.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.3M18.0M20.8M23.7M
 
 
 
 
 
Shares To Calculate EPS Diluted6.3M18.0M20.8M23.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.36-$3.76-$13.63-$9.56
 
 
 
 
 
EPS Diluted-$7.36-$3.76-$13.63-$9.56